The other group (Nassar A et al.), however, investigated caspase-3 expression in 91 breast cancers by immunohistochemistry and found that caspase-3 levels were reduced in carcinoma tissues and correlated with tumor grade, but this had no significant correlation with OS or DFS in patients. The gene discussed is CASP3; the disease is carcinoma.